REPL
Replimune Group, Inc.
NASDAQ · Healthcare · Biotechnology · US
$20.89
+1.16%Leverage
- Debt / equity
- 0.62x
- Net debt / equity
- -0.88x
- Debt / assets
- 0.34x
- Debt / EBITDA
- -0.49x
- Net debt / EBITDA
- 0.70x
Liquidity & coverage
- Current ratio
- 7.11x
- Quick ratio
- 6.90x
- Cash ratio
- 6.76x
- Interest coverage
- -22.53x
- EBITDA / interest
- -21.62x
- Working capital
- $278.5M
Cash & dividend
- FCF / debt
- -1.93x
- Cash flow / debt
- -1.93x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026